“HMPV no cause of concern, has been around since 2001”

Health Secretary reviews situation: No surge in the country of respiratory illness

GN Bureau | January 7, 2025


#Health   #Healthcare   #HMPV  
(Photo: Governance Now)
(Photo: Governance Now)

Union health secretary Punya Salila Srivastava chaired a meeting with states/UTs in a virtual mode on Monday to review the present situation of respiratory illnesses in India and the status regarding the HMPV cases following media reports of surge in HMPV cases in China, and the public health measures for their management.

The meeting was attended by Dr Rajiv Bahl, Secretary (DHR); Dr (Prof) Atul Goel, DGHS; Health Secretaries and officials of States, experts from NCDC, IDSP, ICMR, NIV and State Surveillance Units of IDSP, an official release said Tuesday.

During the meeting, it was reiterated that the data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country. This is also corroborated by the ICMR sentinel surveillance data.  

Srivastava emphasised that there is no cause of concern for the public from HMPV which has been present globally since 2001. She advised states to strengthen and review the ILI/SARI surveillance. She reiterated that an increase in respiratory illnesses is usually seen during the winter months. She also stated that the country is well prepared for any potential surge in respiratory illness cases.

Human metapneumovirus (HMPV) is one of the many respiratory viruses that can cause infections in people of all ages particularly during the winter and early spring months. The virus infection is usually a mild and self-limiting condition and most cases recover on their own.  It was informed that adequate diagnostic facilities are available with the ICMR-VRDL laboratories.

The states were advised to enhance IEC and awareness among the population regarding prevention of transmission of the virus with simple measures such as washing hands often with soap and water; avoid touching their eyes, nose, or mouth with unwashed hands; avoid close contact with people who are exhibiting symptoms of the disease; cover mouth and nose when coughing and sneezing etc.

Comments

 

Other News

Strong El Nino threat over India`s monsoon, food & water security

India is heading into the southwest monsoon season this year under the shadow of a rapidly strengthening El Nino, with meteorologists warning that the climate phenomenon could significantly disrupt rainfall patterns, intensify heat stress and place additional pressure on the country’s agriculture-d

How corporates can nudge real change

The Business Of Business Is (Not) Just Business: How Behavioural Tools Can Drive Real Change Edited by Sutapa Banerjee, with Foreword by Nadir Godrej HarperCollins, 336 pages, Rs 699  

India stopped jailing people for paperwork. Now comes the hard part

A small pharmacist in Rajkot neglects to change a notice in his store under a little-known clause of a public health law. This was not only a non-compliance matter, but also a criminal offence, and a jail sentence was the punishment under the old system. Not a fine. Not a warning. Jail. Now scale

How to make our cities climate-resilient

Indian cities are growing at a pace that our infrastructure and climate can no longer sustain. This rapid urban sprawl increasingly strains urban systems, overshadowing the severe environmental fallout produced in its wake. The repercussions include Urban Heat Island Effect (UHI), Urban Floods, and many mo

Trump’s China setback pushes US to woo India

A week after Donald Trump’s visit to China – the first by an American president in nine years, US secretary of state Marco Rubio arrived in India on May 23 on a four-day visit aimed at resetting Washington DC’s relations with New Delhi and attending the third Quad ministerial meeting.

EU–India FTA 2026: A high‑stakes prescription for Indian pharma and healthcare

India’s pharmaceutical industry stands as one of the world’s market leaders of generic pharmacy with market valuation of USD 50 billion in 2026. Characterised by high volume, low-cost generic manufacturing, with an annual growth rate of 10-12% primarily propelled by exports and domestic demand,





Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter